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Diuretic effect of bumetanide in isolated perfused kidneys of Milan
hypertensive rats. The Milan hypertensive strain of rats (MHS) is
characterized in the prehypertensive phase (4 weeks of age) by a
significantly faster bumetanide-sensitive cell membrane Na,K,Cl-
cotransport as compared to matched normotensive controls (MNS).
The isolated kidney preparation, which allows the study of renal
function under controlled in vitro conditions, was chosen to compare
the natriuretic eff'ct of the loop diuretic, bumetanide, to that of two
other diuretics (amiloride and hydrochlorothiazide) acting on different
parts of the nephron. Concentrations ranging from l0 to lO M were
tested in 4-week-old MHS and MNS. Our results showed that the
natriuretic response to all diuretics was greater in MHS as compared to
MNS when evaluated as absolute Na excretion (UNa); this is likely
because of the faster basal glomerular filtration rate (GFR) in the
hypertensive strain (874 126 in MHS vs. 556 33 sl min g' k
wt in MNS, P < 0.05). However, when calculated either as a difference
from basal values (LUNa*), or per ml of glomerular filtration rate, the
response of MHS kidneys to amiloride and hydrochlorothiazide was
similar in the two strains: LUNa after amiloride at (l0- M was +2.1
0.7 in MHS versus +1.2 0.2 mol . g g k wt in MNS; after
hydrochlorothiazide l0- Mit was +1.7 0.9 in MHS versus +1.1
0.4 moI min' g' k wt in MNS, values not statistically different.
On the other hand, UNa* was disproportionally greater in MHS after
bumetanide (at l0 M +13.5 1.0 in MHS vs. +1.7 0.7
mol. min . g k wt in MNS, P < 0.001). GFR and renal perfusion
flow rate were not modified by the three diuretics. Since isolated
kidneys showed a selectively higher natriuretic response to the loop
diuretic, it is therefore possible to speculate that this class of diuretics
might have a more pronounced natriuretic effect also in vivo in animal
models characterized by a faster Na , K ,Cl — cotransport. These data
provide a working hypothesis for controlled studies in hypertensive
patients with the same cotransport abnormality.
Several abnormalities in cell membrane ion transports have
been found in humans with essential hypertension, mainly using
red blood cells as an experimental model [1—4]. One of these
abnormalities is observed in the Na ,K ,C1 cotransport,
defined as the ouabain-resistant, bumetanide-sensitive Na
pathway [5]. Na,K,Cl outward cotransport has been re-
ported to be either slower or faster in erythrocytes of essential
hypertensives as compared to matched controls [6, 7], with a
bimodal frequency distribution curve suggesting different sub-
groups of patients [8].
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In genetic models of hypertension in the rat, Na,K,Cl
cotransport has also been found to be either decreased, such as
in the spontaneously hypertensive rat (SHR) [9], or increased,
such as in the Milan hypertensive strain (MHS) [10].
In fact MHS rats have a faster Na,K,Cl cotransport
compared to normotensive controls, not only in erythrocytes,
but also in vascular smooth muscle cells (VSMC) and thick
ascending limb tubular cells, as shown by previous in vitro
studies [11, 121. In addition, other abnormalities (such as lower
cell volume, lower intracellular Na content compared to
controls, etc.) have also been found to be similar in MHS
erythrocytes and kidney tubular cells [13—15]. Moreover, young
prehypertensive MHS are characterized by a faster tubular Na
reabsorption linked to the subsequent development of hyper-
tension [10].
For all these reasons the Milan strain might be considered as
an interesting tool for correlating Na transport abnormalities
and kidney function in hypertension.
It is in fact possible that loop diuretics, which selectively
inhibit Na,K,Cl cotransport, might have a more pro-
nounced natriuretic effect in this strain of rats as compared to
their normotensive controls. In order to test this hypothesis, the
activity of the loop diuretic, bumetanide, in comparison with
other diuretics acting on different parts of the nephron, such as
amiloride and hydrochiorothiazide, was studied using the iso-
lated perfused kidney. In this preparation, controlled extracel-
lular ion and drug concentrations can be obtained in the absence
of extrarenal nervous or humoral influences.
Methods
Kidney perfusion
Kidneys from male MHS (28 1.0 days old, mean body
weight 82.9 1.3 g, N = 26) and age-matched normotensive
controls (mean body weight 83.1 0.9 g, N = 25) were isolated
and perfused according to the technique previously described
[16].
The mean kidney weights (kidney wt) were 0.36 0.05 and
0.44 0.06 g (P < 0.01) for MHS and MNS, respectively.
Briefly, under Na pentobarbital anesthesia (45 mg/kg i.p.),
the abdominal aorta rather than the renal artery itself was
cannulated retrogradely (19 gauge needle) to permit perfusion of
kidneys from young animals. Collateral vessels between the
insertion point and the right renal artery were all ligated. The
right ureter was cannulated (0.5 cm segment of PE-lO con-
nected to PE-50, Clay Adams, Parsippany, New Jersey, USA)
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and the kidney was then removed and transferred to a constant-
temperature (37.0 0.5°C) recirculating perfusion apparatus.
The perfusion pressure distal to the tip of the cannula was
approximately matched to the mean arterial pressure deter-
mined previously in separate groups of conscious rats of the
same age: 92.5 and 100 mm Hg for young MNS and MHS,
respectively.
These pressures were kept constant throughout the experi-
ment by adjusting perfusion flow with a needle valve (Nupro
Company, Ohio, USA) placed in parallel with the arterial line.
Perfusion flow was measured by an in-line flow meter (A.H
Thomas, Philadelphia, Pennsylvania, USA). Two in-line 8 pm
filters (Millipore Corporation, Bedford, Massachusetts, USA)
continuously filtered the perfusate during the experiment.
The perfusion medium was a Krebs-Henseleit buffer solution
(K-H) containing 6.7% wt/vol bovine serum albumin (fraction
V, Miles Laboratories, Elkhart, Indiana, USA).
The composition of the buffer (mM) was: NaCI 113, KCI 4.6
Na2HPO4 1.8, NaH2PO4 0.6, MgSO4 1.17, NaHCO3 25 and
CaCl2 1.00. The pH was maintained at 7.45 with a 5% CO2-95%
02 mixture.
In addition the medium contained: glucose 7.5 m, a mixture
of amino acids (Solamin, Pierrel, Italy) as previously described
[17], vasopressin (40 ng/lOO ml), aldosterone (12.5 ng/lOO ml),
corticosterone (1.6 g/l00 ml) and, Cr34VEDTA (2.0 mM) for
estimation of renal clearance. Urinary and evaporative losses
were replaced by an infusion of saline with the same composi-
tion as K-H, except that Na concentration was 80 m and K
concentration was 25 mi. After 30 minutes of equilibration,
three control samples of five minutes each (both urine and
perfusate) were taken followed by three five-minute clearance
periods for each concentration of diuretic. Either bumetanide,
amiloride or hydrochlorothiazide were added to the medium
cumulatively, (tenfold increasing concentrations from l0— to
io- M), Further groups of MHS (N = 8) and MNS (N = 8)
kidneys were vehicle-treated and used as time-dependent con-
trols.
Analyses and calculations
Urine flow rate (pVmin) was determined gravimetrically in
preweighed vials. Na and K concentrations (mol/ml), were
measured by flame photometry with lithium as the internal
standard in both perfusate and urine samples (IL 243 Lexing-
ton, Massachusetts, USA); Cr3/EDTA concentration was de-
termined by spectrophotometry (Yasco Uvidec 610, Tokyo,
Japan).
Functional parameters included: glomerular filtration rate
(GFR), urinary Na and K excretion (UNa; UK*), calculated
with standard formulas; sodium excretion (UNa*) per ml of
glomerular filtration rate (Cl1®0) was calculated as following:
UNa(/1mol min g kidneywt)UNa/ClI®O = __________________________
GFR(pi. mm . g -' kidney wt)
1000 (l. mm -' g - l kidney wt)
Drugs
Bumetanide was from Sigma Tau (Italy). Amiloride hydro-
chloride, hydrochlorothiazide and all other compounds and
*
1 I I
chemicals were from Sigma (Sigma Chemical Co, St. Louis,
Missouri, USA).
Statistics
All values are expressed as mean SEM and when appropri-
ate are corrected per gram of wet kidney weight. Data were
analyzed by unpaired analysis of variance. When the F-value
indicated overall significance, specific comparisons were made
using the Duncan's test [18].
All comparison differences were considered significant when
P < 0.05.
Results
Renal hemodynamics
Renal perfusion flow (RPF) in control rats was similar in the
two strains throughout the experimental period (Fig. 1). Renal
vascular resistence (RVR) was 9.5 0.7 in MHS and 8.3 0.8
mm Hg. mm m1' in MNS at the beginning of perfusion (not
statistically different). Addition of any of the three diuretics to
the medium did not modify RPF or RVR in either strain.
GFR of control MHS was significantly higher than GFR of
MNS, as previously reported for rats of this age [161; at the
beginning of perfusion GFR of MHS was in fact 873.8 125.7
versus 555.8 33.5 a1. min' . g' kidney wt in MNS (P <
0.05).This difference remained unchanged throughout the ex-
periment both in control and diuretic-perfused kidneys.
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Fig. 1. Time course of overall function in isolated perfused kidneys
from MHS (•, N 8) and MNS rats (0, N = 8) after 30 mm of
equilibration. Abbreviations are: RPF, renal perfusion flow; GFR,
glomerular filtration rate; % Na reabsorption, fractional Na reabsorp-
tion. Data are mean sEM; * P < 0.05; ** P < 0.01 by unpaired t-test.
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Fig. 2. Effect of three different diuretics on urinary sodium excretion
(UN6c) of isolated kidneys from MHS rats (closed symbols) and MNS
rats (open symbols) (N 6, with the exception of amiloride-treated
MNS kidneys, N = 5). Controls (•--•, MHS; MNS) received
the vehicle only (N = 8). Data are mean SEM; * P <0.05; ** P <0.01;
'6 P < 0.001, from corresponding control values.
Urine volume and urinary Na + excretion
Baseline urinary Na excretion (UNa+) was significantly
higher in MHS as compared to MNS (2.30 0.43 vs. 0.57
0.08 mol . min' . g' kidney wt, P <0.05, as well as urinary
volume (U); Figs. 2 and 3). However, fractional Na reabsorp-
tion was similar in the two strains, as shown in Figure 1. In the
control kidneys these parameters remained unchanged through-
out the experimental period.
Amiloride (from l0— to iO M) had no effect on urinary
volume (U) whereas it significantly (P < 0.01) increased UNa+
in a concentration-dependent manner, reaching a plateau at
i0 M in both strains. Although the absolute value of UNa* was
always greater in MHS than in MNS (P < 0.05), there was no
significant difference between MHS and MNS in their re-
sponses to amiloride (UNa from vehicle-treated groups) due
to the differing baseline values of UNa in the two strains (Table
I).
Bumetanide (from l0— to iO M) caused a concentration
related increase of both U,,, and UNa* with a threshold of 106 M
in MHS and of l0- M in MNS. In contrast to the results
obtained with amiloride, the bumetanide-induced increase in
UNa+ (UNa*) was greater in MHS at all concentrations (data
referring to iO M are reported in Table I). This disproportion-
ally greater response of MHS was independent from differences
in basal tubular load and natriuresis as confirmed by data
reported in Table 2, showing that it also remained when Na
Fig. 3. Effect of three different diuretics on urinary volume (Up) of
isolated kidneys from MHS rats (closed symbols) and MNS rats (open
symbols) (N = 6, with the exception of amiloride-treated MNS kidneys,
N = 5). Controls (•--•, MHS; O--, MNS) received the solvent only(N = 8). Data are mean SEM; * P < 0.05; *** P < 0.001, from
corresponding control values.
Treatment
Rat
strain
UNa* excretion
j.unol min' . g' kidney wt
Amiloride MNS
MHS
+ 1.18 0.25 (+169.3 30.7%)
NS
+2.09 0.73 (+77.3 25.7%)
Bumetanide MNS
MHS
+ 1.67 0.67 (+239.3 95.7%)
P < 0.001 MHS vs. MNS
+ 13.5 1.01 (+437.2 32.5%)
Hydrochlorothiazide MNS
MHS
+ 1.14 0.38 (+ 163.1 55.1%)
NS
+ 1.73 0.97 (+55.9 31.2%)
excretion was expressed per ml of glomerular filtration rate, U,,,
paralleled the functional behavior of UNa+ in both strains.
Hydrochlorothiazide did not modify U,,, or UNa in concentra-
tions ranging from l0— to l0— even at iO M the effect was
modest in both strains. Table 1 also shows the percent increase
in UNa' after the maximal concentration (l0— M) of the three
diuretics; only after bumetanide was the percent increase in
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Table 1. Effect of the highest concentration (l0 M) of each diuretic
on urinary sodium excretion in isolated kidneys from both strains of
rats
Values show absolute (UN.) and % differences between diuretic-
treated and matched vehicle-treated rats. Data are means SEM (N
6, with the exception of amiloride-treated MNS kidneys, N = 5).
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Table 2. Effect of bumetanide (from i0- to 104M) on urinary Na
excretion corrected for ml of glomerular filtration rate (UNa*/ClI)
in isolated kidneys from MHS and MNS rats
UN+/Cllj mo1.min'.g kidney wt
Treatment EM] MHS MNS pa
Control — 2.7 0.5 1.1 0.1 <0.01
N = 16
Bumetanide l0 4.1 0.6 1.1 0.2 <0.01N = 12 7.3 2.1 1.4 0.2 <0.05i0 20.5 1.8 3.3 0.7 <0.001
l0— 32.0 3.6 7.5 1.5 <0.001
UNa+ greater in MHS as compared to MNS, whereas the
contrary was true after amiloride and hydrochlorothiazide.
Urinary potassium excretion
As previously observed for U,,, and UNa*, urinary K excre-
tion (UK+) was significantly higher (P < 0.001) under basal
conditions in isolated MHS kidneys as compared to MNS (1.7
0.19 in MHS vs. 0.6 0.07 mo1. min g1 kidney wt in
MNS, respectively; Fig. 4).
Because of its potassium-sparing effect, amiloride induced a
significant decrease in UK* in both strains. Already at the first
coicentration (10—v M), UK* was almost abolished in both
strains (0.2 0.03 in MHS vs. 0.2 0.01 tmol . min g
kidney wt in MNS).
Bumetanide significantly increased UK. starting at iO— M in
both strains, yet the effect was greater in MHS (+ 1.8 0.22 in
MHS vs. +0.35 0.17 moI . min . g kidney wt in MNS,
P < 0.01).
The kaliuretic effect following hydrochlorothiazide adminis-
tration was similar in kidneys from MHS and MNS with a
threshold concentration of l05M in both strains (at iO- M:
+1.0 0.22 in MHS vs. +0.81 0.27 tmol . min' . g'
kidney wt in MNS, not statistically different).
Discussion
The major limitations in using cell-free Krebs perfused iso-
lated kidney preparations are related to the time dependent
changes that occur during the perfusion. However, in the
control kidneys from both MNS and MHS rats under our
experimental conditions urinary volume, electrolyte excretion
as well as RPF and RVR remained remarkably stable through-
out the experiment. If we compare isolated kidney function
with the in vivo values, a lower GFR than in intact conscious
rats of the same strain is found as previously described [161.
Other parameters, such as urine flow and fractional Na
urinary excretion, are similar in the present experiments to the
in vivo data, likely because of the addition to the perfusion
medium of aldosterone, vasopressin and aminoacids which
were shown to improve kidney function in vitro [19, 20].
However, under these experimental conditions, where sys-
temic, nervous or humoral feedback mechanisms are lost, the
difference in GFR between MHS and MNS is greater than in
vivo; this leads to a greater tubular load in MHS compared to
MNS with a consequent increase in UNa* in spite of the
accelerated absolute tubular reabsorption in this strain shown in
vivo [21]. The defective oxygen delivery capability of the
perfusion in vitro system [22, 23] may contribute to the failure
of MHS tubular reabsorption to cope with the increased load.
These mechanisms, together with an increased load delivery to
both the thick ascending limb and the distal convoluted tubule
may cause a difference in the overall tubular response to
diuretics between the two strains in a manner that is difficult to
predict. For these reasons, we studied the effects of three
different diuretics in order to rule out a possible aspecific
difference between MHS and MNS, independent of the mech-
anism of action of the diuretics. Our results show that bumet-
anide causes a selectively greater diuretic and natriuretic re-
sponse in MHS than in MNS.
Moreover, the threshold bumetanide concentration seems to
be lower in MHS than in MNS while with the other two
diuretics no difference in their threshold concentrations was
found. If we express the natriuretic effect as percent increase
from control values, only the response to bumetanide was
greater in MHS as compared to MNS. The contrary was true for
both amiloride and hydrochlorothiazide (Table 1).
The difference in tubular load between strains cannot entirely
account for the greater natriuresis observed in MHS as shown
by the data corrected per ml of glomerular filtration rate. On the
other hand we have to take into account that the increased load
may cause per se an accelerated tubular Na reabsorption in
MHS. However, we do not favor this explanation as Nat, K,
C1 cotransport has also been found to be increased in MHS
erythrocytes and cultured VSMC, where extracellular influences,
such as load, are avoided [10, 121. Data in the literature have
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Fig. 4. Effect of three different diuretics on urinary potassium excre-
tion (UK) ofisolated kidneys from MHS rats (closed symbols) and
MNS rats (open symbols) (N = 6, with the exception of amiloride-
treated MNS kidneys, N = 5). Controls (•--•, MHS; K--, MNS)
received the solvent only (N = 8). Data are mean sErf; * P < 0.05;
** P < 0.01; *** P < 0.001, from corresponding control values.
1088 Salvati et al: Diuretic action in perfused kidneys
shown that in isolated kidneys from normal rats, where tubular
load was artifically augmented by increasing perfusion pres-
sure, the percent increase in UNa+ after the ioop diuretic
furosemide, was greater under conditions of lower tubular load
[24].
Another limitation in interpreting our results is that we don't
know whether the bumetanide pharmacokinetics and tubular
secretion were similar in the two strains, and therefore we
cannot conclude that the greater effect of bumetanide in MHS
was actually due to its higher affinity for Na ,K ,C1 cotrans-
port in this strain. On the other hand our hypothesis is consis-
tent with data obtained by studying the effect of bumetanide on
Na ,K ,C1 cotransport in isolated vesicles prepared from the
thick ascending limb membranes of MHS and MNS. In fact
under those experimental conditions a greater bumetanide-
sensitive Na flux and also a greater affinity for bumetanide
were observed in MHS [11]. These findings, together with the
above reported data on erythrocytes and on VSMC, suggest
that an intrinsic defect in membrane function might be present
in MHS kidneys. Beside the inhibition of Na transport across
the luminal membrane of the ascending limb, bumetanide may
also increase Na excretion through the depression of the
tubuloglomerular feedback (TGF) mechanism [25]. However,
this additional effect of bumetanide may not be present in MHS
since the TGF is already depresseJ in young MHS compared to
matched MNS [26].
Amiloride has been shown to inhibit Na-H countertrans-
port in the proximal tubule [27], however, this activity cannot
explain its modest natriuretic effect, due to a compensatory
increase in Na reabsorption in the ioop of Henle [28]. Hence
an action of amiloride in the distal tubule is the likely explana-
tion of its observed effects on UNa* and UK* in kidneys isolated
from MHS and MNS [29, 30].
Hydrochiorothiazide-induced natriuresis was negligible up to
l0 M. On the other hand kaliuresis became significant in both
strains at a concentration ten times lower than that which
elicited natriuresis. This could be due either to the augmented
Na delivery to the distal nephron or to a stimulating effect of
hydrochiorothiazide on K secretion in that nephron segment
[25].
In conclusion the isolated kidney proved to be a suitable
model for studying the mechanism of action of diuretics, as
renal function changes induced by amiloride, bumetanide and
hydrochlorothiazide were consistent with their known renal
activities in humans.
Moreover, the results described here show that the diuretic
effect of bumetanide appears at a lower concentration in MHS
than in MNS. Also the maximal diuretic activity of bumetanide
was greater in MHS, while the effects of the other two diuretics
were similar in the two strains.
The most likely explanation for this greater effect of bumet-
anide in the hypertensive strain is that a greater portion of Na
transport in MHS tubular cells is mediated by cotransport as
suggested by previous in vitro studies [11, 13].
However, the greater natriuretic response to a ioop diuretic is
not a common characteristic of all hypertensive rat strains; in
fact the natriuretic response to furosemide was significantly
diminished in isolated kidneys from spontaneously hyperten-
sive rats (SHR) as compared to kidneys from Wistar Kyoto
normotensive controls (WKY) [31]. This is relevant in view of
the finding that bumetanide-sensitive sodium extrusion was
lower in SHR erythrocytes than it was in WKY, indicating
abnormally low outward Na ,K ,C1 cotransport [9].
The relevance of these in vitro findings to the in vivo situation
remains to be established. However, we can speculate that loop
diuretics might have a more pronounced natriuretic effect in
that subgroup of hypertensive patients characterized by an
increased Na,K,Cl cotransport in red blood cells.
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